Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In March, short sellers collectively increased their negative bets on the broader healthcare industry, as indicated by a rise ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

RELATED: Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga A Pfizer spokesperson told the AP that Pfizer will stop testing danuglipron in combination with other ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

Pfizer PFE announced that it is discontinuing the development of danuglipron, its investigational oral GLP-1 receptor agonist (GLP-1 RA), which is being developed to treat obesity. The decision ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop ... Bayer, GSK, Moderna, Pfizer, and Sanofi - are all racing to develop mRNA influenza vaccines.